Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17882-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#17882-1-AP, RRID:AB_10859819
- Product name
- LIN9 antibody
- Antibody type
- Polyclonal
- Description
- LIN9 antibody (Cat. #17882-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis.
The dual role of the DREAM/G2M pathway in non-tumorigenic immortalization of senescent cells.
Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple-negative breast cancer.
LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP.
Chen Y, Zhou Y, Feng X, Wu Z, Yang Y, Rao X, Zhou R, Meng R, Dong X, Xu S, Zhang S, Wu G, Jie X
Cell death & disease 2024 Jan 31;15(1):104
Cell death & disease 2024 Jan 31;15(1):104
The dual role of the DREAM/G2M pathway in non-tumorigenic immortalization of senescent cells.
Tian J, Jiang L, Li H, Dan J, Luo Y
FEBS open bio 2024 Feb;14(2):331-343
FEBS open bio 2024 Feb;14(2):331-343
Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple-negative breast cancer.
Pascual-Reguant L, Serra-Camprubí Q, Datta D, Cianferoni D, Kourtis S, Gañez-Zapater A, Cannatá C, Espinar L, Querol J, García-López L, Musa-Afaneh S, Guirola M, Gkanogiannis A, Miró Canturri A, Guzman M, Rodríguez O, Herencia-Ropero A, Arribas J, Serra V, Serrano L, Tian TV, Peiró S, Sdelci S
EMBO molecular medicine 2023 Dec 7;15(12):e18459
EMBO molecular medicine 2023 Dec 7;15(12):e18459
LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP.
Lai H, Wang R, Li S, Shi Q, Cai Z, Li Y, Liu Y
Science China. Life sciences 2020 Mar;63(3):419-428
Science China. Life sciences 2020 Mar;63(3):419-428
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The LIN9 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human LIN9. This antibody recognizes human, mouse, rat antigen. The LIN9 antibody has been validated for the following applications: ELISA, WB analysis.